Catalyst Wire Dossier Catalyst Wire Dossier

Palifermin

palifermin · Amgen
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Palifermin, covering 2012-01-30 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]

See pricing